PB

Patrick Baeuerle

Excutive Partner at MPM Capital

Greater Munich Metropolitan Area

Overview 

Patrick Baeuerle is currently the Managing Director at MPM Capital, with a background in lifesciences and oncology. His career highlights include serving as Vice President Research at Amgen Research GmbH and Chief Scientific Officer at Micromet, Inc., while also investing in companies like TCR2 during their Series B funding round.

Work Experience 

MC

MPM Capital

  • Excutive Partner

    2015 - Current

    Financing and building of start-up companies

MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.

mpmbioimpact.com
AR

Amgen Research (Munich) GmbH

  • Vice President Research; General Manager

    2012 - 2015

    Site management Translational science BiTE antibody development

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Raised $28,500,000,000.00 from Citibank and Bank of America.

amgen.com

Micromet, Inc.

  • Chief Scientific Officer

    1998 - 2012

    Preclinical development CMC, bioanalytics, antibody engineering, non-clinical development Executive functions

Tularik, Inc.

  • Director Drug Discovery

    1996 - 1998

    Small molecule drug discovery Highthroughput screening Assay development Hit characterization Basic research Inflammation programm management Alliance management

Albert Ludwigs University of Freiburg, Institute for Biochemistry and Molecular Biology

  • Professor and Chairman

    1994 - 1996

    Basic research on NF-kappa B Pro-inflammatory signal transduction Teaching biochemistry to medical students

Education 

Investments 

TCR2

Series A

Total funding: $170M

Articles About Patrick

Relevant Websites